Skip to content
Synopulse
  • The Brief
    • Quick
    • In Depth
    • Editor’s Pick
    • Findings
  • Reports
    • The beats
      • Catalyst
      • AccessWatch
      • DealPulse Signal
      • DealPulse Report
    • Analysis
      • The Throughline
      • The Top Line
      • The Forecast
    • Coverage
      • ShowFloor
      • The Arena
  • The Pulse
    • NeuroPulse
    • OrphanPulse
  • Topics
    • By subject
      • Deals
      • Regulatory
      • Market Access
      • Pricing & Reimbursement
      • Legal & Policy
    • By technology
      • Antibody
      • Cell & Gene Tx
      • Drug conjugates
      • AI/ML
      • Digital Health
      • Radiopharma
    • By therapy area
      • Neurology
      • Oncology
      • Rare Diseases
      • Cardio-Metabolic
      • Immunology & Inflammation
      • Orthopaedics

Health Technology Assessment (HTA)

Korea Cleared Two Diagnostics on One Day, and Both Remove a Specialist

August 12, 2026 by Athithi Verma
Korea Cleared Two Diagnostics on One Day, and Both Remove a Specialist

Nobody gained insurance access. Designation is the gate before the negotiation. The real story is that both lead technologies remove a specialist.

Categories Access Read, Diagnostics, Market Access, Oncology, Pricing & Reimbursement, Quick, The Brief Tags Health Technology Assessment (HTA), HIRA, JAK2 V617F, Ministry of Health and Welfare, NECA, nHTA, Pricing & Reimbursement, South Korea

HAS Stroke Update Transforms Access on World Stroke Day

November 3, 2025October 29, 2025 by Athithi Verma
Stroke

HAS strengthens stroke management for faster, equitable emergency care access.

Categories Market Access, News Tags Health Technology Assessment (HTA), HTA, Stroke

RedETSA Convenes 38 HTA Institutions for Americas Summit

June 9, 2025 by Shajini

Regional HTA network addresses equity, economic evaluation, and adaptation frameworks.

Categories Market Access, News Tags Evidence-based Decision, Health Technology Assessment (HTA), Summit
Synopulse Weekly Pulse: Access Decisions, Regulatory Events & Market Dynamics, Week of Nov 24 2025

Synopulse Weekly Pulse – November 24, 2025

Read Now
  • Access Read
  • AI/ML
  • Analysis
  • Antibody
  • Approval
  • Cardio-Metabolic
  • Cell & Gene Tx
  • CI read
  • Clinical Read
  • Coverage
  • Deal Read
  • DealPulse
  • DealPulse Report
  • DealPulse Signal
  • Deals
  • Diagnostics
  • Digital Health
  • Drug conjugates
  • Drug Repurposing
  • Editor's Pick
  • Findings
  • Immunology & Inflammation
  • In Depth
  • Launch
  • Legal & Policy
  • Market Access
  • MedTech
  • Neurology
  • NeuroPulse
  • News
  • Oncology
  • Ophthalmology
  • Organ On Chip
  • OrphanPulse
  • Orthopaedics
  • Peptide
  • Pricing & Reimbursement
  • Pulmonology
  • Quick
  • Radiopharma
  • Rare Diseases
  • Regulatory
  • Reports
  • RNA
  • Science Read
  • ShowFloor
  • Small Molecule
  • The beats
  • The Brief
  • The Pulse
  • The Throughline
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • March 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • February 2025
  • January 2025
  • October 2024
  • September 2024
Synopulse
Contact Us

Explore Synopulse

  • NeuroPulse
  • Deals
  • Market Access
  • Industry Trends
  • Regulatory

About

  • About Synopulse
  • Contact Us
  • Announcements
© 2026 Synopulse • Built with GeneratePress